{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:41:13Z","timestamp":1775274073897,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.clon.2010.09.006","type":"journal-article","created":{"date-parts":[[2010,10,10]],"date-time":"2010-10-10T04:25:47Z","timestamp":1286684747000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"K.N.","family":"Kancherla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Oksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.D.","family":"Prestwich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fosker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Dyker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9538","key":"10.1016\/j.clon.2010.09.006_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clon.2010.09.006_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clon.2010.09.006_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.clon.2010.09.006_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clon.2009.05.007","article-title":"Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck","volume":"21","author":"Matzinger","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.clon.2010.09.006_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2008.06.007","article-title":"Hypofractionated, palliative radiotherapy for advanced head and neck cancer","volume":"89","author":"Agarwal","year":"2008","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2010.09.006_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/019459988709700102","article-title":"Treatment of patients with stage IV cancer: do the ends justify the means?","volume":"97","author":"Burns","year":"1987","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1368-8375(97)00073-0","article-title":"Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavourable prognostic factors and severe symptoms","volume":"34","author":"Minatel","year":"1998","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.clon.2010.09.006_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2004.03.009","article-title":"Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study","volume":"71","author":"Mohanti","year":"2004","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0360-3016(82)90511-9","article-title":"Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer","volume":"8","author":"Weissberg","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2005.10.008","article-title":"The \u2018QUAD SHOT\u2019 \u2014 a phase II study of palliative radiotherapy for incurable head and neck cancer","volume":"77","author":"Corry","year":"2005","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2010.09.006_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0360-3016(93)90012-K","article-title":"Phase I\u2013II study of multiple daily fractions for palliation of advanced head and neck malignancies","volume":"25","author":"Paris","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2010.09.006_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.radonc.2007.10.020","article-title":"Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment \u2013\u201cHypo Trial\u201d","volume":"85","author":"Porceddu","year":"2007","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.clon.2010.09.006_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.1992.196","article-title":"A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status","volume":"65","author":"Medical Research Council Lung Cancer Working Party","year":"1992","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.1991.62","article-title":"Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party","volume":"63","year":"1991","journal-title":"Br J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2010.09.006_bib15","first-page":"54","article-title":"The role of palliative radiotherapy in advanced head and neck cancer","volume":"6","author":"Hodson","year":"1996","journal-title":"Can J Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0196-0709(94)90057-4","article-title":"Treatment of head-and-neck carcinoma with noncurative intent","volume":"15","author":"Lucente","year":"1994","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.clon.2010.09.006_bib17","series-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"2002"},{"key":"10.1016\/j.clon.2010.09.006_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organisation for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2010.09.006_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"17","key":"10.1016\/j.clon.2010.09.006_bib20","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.2005.05.3348","article-title":"Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck","volume":"24","author":"Colevas","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(01)00358-9","article-title":"Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial","volume":"60","author":"Bentzen","year":"2001","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2010.09.006_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/095530098142211","article-title":"Outstanding issues in radiation dose-fractionation studies","volume":"73","author":"Hendry","year":"1998","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"10.1016\/j.clon.2010.09.006_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-8140(92)90226-K","article-title":"The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy","volume":"24","author":"Slevin","year":"1992","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.09.006_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clon.2007.11.003","article-title":"Optimum overall times II: extended modelling for head and neck radiotherapy","volume":"20","author":"Fowler","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"800","key":"10.1016\/j.clon.2010.09.006_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1259\/0007-1285-67-800-790","article-title":"The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor","volume":"67","author":"Roberts","year":"1994","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.clon.2010.09.006_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-8140(93)90175-8","article-title":"The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data","volume":"29","author":"Roberts","year":"1993","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655510003766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655510003766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:36:36Z","timestamp":1760542596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655510003766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0936655510003766"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2010.09.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2010.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}